Status:

COMPLETED

Carbohydrate-Protein Supplementation During Endurance Running

Lead Sponsor:

The University of Tennessee, Knoxville

Conditions:

Supplementation During Endurance Performance

Eligibility:

MALE

18-55 years

Phase:

NA

Brief Summary

The purpose of this study is to assess whether the greater performance benefits from ingesting carbohydrate-protein supplements during endurance running, in comparison to the traditionally used carboh...

Detailed Description

The purpose of this study is to determine whether the performance benefits from consuming a carbohydrate-protein (CHO-P) supplement, such as Accelerade, during endurance exercise, as opposed to the tr...

Eligibility Criteria

Inclusion

  • Males aged 18-55 years old
  • BMI in the healthy range, 18.5-24.9
  • Run 45-90+ minutes at least 4 days per week
  • Engage in running this frequency and duration for at least 4 weeks prior to the phone screen
  • Engage in a run consisting ≥10 miles in length for at least 2-4 occasions per month for at least 2 months prior to the phone screen
  • No previous history of heart conditions
  • No shortness of breath or chest pain experienced during running or daily activities
  • No bone or joint problems experienced during running or daily activities

Exclusion

  • Females and males under the age of 18 and over the age of 55
  • Females are excluded from this study in order to prevent any potential factors associated with the female athlete triad and endurance performance outcomes.
  • BMI below 18.5 or greater than 24.9
  • Does not meet all other criteria listed (#3-6)
  • Allergies to products containing milk, soy, or aspartame
  • Severe allergies to eggs, wheat, tree nuts, fish, crustaceans, shellfish products (Accelerade, the CHO-P supplement, is made in a facility that processed these products)
  • Refusal to consume any of the supplements, and/or extreme dislike of the supplements
  • Refusal to complete the specified distance of the time trials

Key Trial Info

Start Date :

August 1 2009

Trial Type :

INTERVENTIONAL

Allocation :

ACTUAL

End Date :

April 1 2010

Estimated Enrollment :

12 Patients enrolled

Trial Details

Trial ID

NCT00972387

Start Date

August 1 2009

End Date

April 1 2010

Last Update

April 5 2018

Active Locations (1)

Enter a location and click search to find clinical trials sorted by distance.

Page 1 of 1 (1 locations)

1

Health Physical Education and Recreation Building

Knoxville, Tennessee, United States, 37996